Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paroxetine versus placebo for women in midlife after hormone therapy discontinuation

Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. Am J Med. 2008; 121(2):159-162.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.